MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
British Journal of Haematology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

778 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
778 works in the cohort · of 4,299,418page 3 of 16

Labels cover 1 of 778 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 778 of 778 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Impact of central nervous system (<scp>CNS</scp>) prophylaxis on the incidence and risk factors for <scp>CNS</scp> relapse in patients with diffuse large <scp>B</scp>‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
Hany R. Guirguis, Matthew C. Cheung, Mervat Mahrous, Eugenia Piliotis, Neil L. Berinstein, Kevin Imrie +2 more
2012· review· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
84
citations
affunlabeled
Phase <scp>IA</scp>/<scp>II</scp>, multicentre, open‐label study of the <scp>CD</scp>40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐<scp>H</scp>odgkin or <scp>H</scp>odgkin lymphoma
Michelle A. Fanale, Sarit Assouline, John Kuruvilla, Philippe Solal‐Céligny, Dae Seog Heo, Gregor Verhoef +9 more
2013· article· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · metaepi_narrow
77
citations
affunlabeled
MOZ/TIF2‐induced acute myeloid leukaemia in transgenic fish
Julia Zhuravleva, Jérôme Paggetti, Laurent Martin, Arlette Hammann, Éric Solary, Jean Bastié +1 more
2008· article· en· British Journal of Haematology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
76
citations
afffundunlabeled
The molecular basis for the thalassaemias in Sri Lanka
Christopher A. Fisher, Anuja Premawardhena, Shanthimala de Silva, Giathra Perera, Shabna Rajapaksa, Nancy Olivieri +2 more
2003· article· en· British Journal of Haematology· Medicine
distilled prediction:candidate · noneconsensus · none
74
citations
aboutno affunlabeled
Novel therapies for multiple myeloma
Toshiaki Hayashi, Teru Hideshima, Kenneth C. Anderson
2002· review· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
74
citations
affunlabeled
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of <scp>SWOG</scp> S0325, an intergroup randomized <scp>PHASE II</scp> trial in newly diagnosed chronic phase chronic myeloid leukaemia
Michael W. Deininger, Kenneth J. Kopecky, Jerald P. Radich, Suzanne Kamel‐Reid, Wendy Stock, Elisabeth Paietta +8 more
2013· article· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · none
64
citations
afffundaboutunlabeled
Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis
Heather A. Leitch, Ambica Parmar, Richard A. Wells, Lisa Chodirker, Nancy Zhu, Thomas J. Nevill +18 more
2017· article· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · none
64
citations
← previousnext →

How this was built: Screen · Findings · About